ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Cash and short-term investments (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $5.6B | −23.1% | 4.6% | 3.9% |
| Cash and short-term investments (Q2 2026) | $5.6B |
|---|---|
| YoY | −23.1% |
| 5-year CAGR | 4.6% |
| 10-year CAGR | 3.9% |
Cash and short-term investments
| Period | Cash | YoY |
|---|---|---|
| 2025 | $8.9B | +12.2% |
| 2024 | $8.0B | +9.5% |
| 2023 | $7.3B | −28.4% |
| 2022 | $10.2B | −0.8% |
| 2021 | $10.2B | +43.4% |
| 2020 | $7.1B | +72.7% |
| 2019 | $4.1B | +1.3% |
| 2018 | $4.1B | −57.5% |
| 2017 | $9.6B | −48.8% |
| 2016 | $18.8B | +206.5% |
| 2015 | $6.1B | +37.3% |
| 2014 | $4.5B | −44.9% |
| 2013 | $8.1B | −46.6% |
| 2012 | $15.2B | +87.4% |
| 2011 | $8.1B | +6.2% |
| 2010 | $7.6B | −31.1% |
| 2009 | $11.1B | +79.8% |
| 2008 | $6.2B | +118.1% |
| 2007 | $2.8B | — |